Skip to main content

Protracted Radiation Exposure Linked to Hematologic Cancer Mortality

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 24, 2024.

via HealthDay

THURSDAY, Oct. 24, 2024 -- Protracted low-dose exposure to ionizing radiation among radiation-monitored workers is associated with mortality due to some hematologic malignancies, according to a study published online in the October issue of The Lancet Hematology.

Klervi Leuraud, Ph.D., from the Institut de Radioprotection et de Sûreté Nucléaire in Fontenay-aux-Roses, France, and colleagues examined the associations between radiation dose and mortality due to hematologic malignancies in a cohort of 309,932 radiation-monitored workers employed for at least one year by nuclear facilities in France, the United Kingdom, and the United States.

The researchers found that a linear model described the association between cumulative dose to red bone marrow, lagged two years, and leukemia (excluding chronic lymphocytic leukemia; excess relative rate per Gy, 2.68), which was not modified by neutron exposure, internal contamination monitoring status, or period of hire. For chronic myeloid leukemia and myelodysplastic syndromes alone or combined with acute myeloid leukemia, positive associations were also seen (excess relative rates per Gy, 9.57, 3.19, and 1.55, respectively). For acute lymphoblastic leukemia or chronic lymphocytic leukemia, no significant association was seen. There was a positive association between radiation dose and multiple myeloma (excess relative rate per Gy, 1.62); minimal evidence of association was seen between radiation dose and non-Hodgkin or Hodgkin lymphoma mortality.

"Studies of people exposed to low doses of radiation add to our understanding of radiation risks at the exposure levels of contemporary concern, and thus can inform radiation protection efforts," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Read this next

Presurgical Ablative Radiotherapy + Chemo Improves Pathologic Outcomes in Pancreatic Cancer

FRIDAY, July 11, 2025 -- Adding stereotactic ablative radiotherapy (SAbR) to neoadjuvant chemotherapy improves pathologic outcomes for patients diagnosed with pancreatic cancer...

Risk for Severe COVID-19 Elevated for Childhood Cancer Survivors

FRIDAY, July 11, 2025 -- Childhood cancer survivors have a lower risk for registered COVID-19 infection but a higher risk for severe COVID-19, according to a study published...

Radiation Therapy Can Promote Amphiregulin, Which Increases Growth of Metastases

THURSDAY, July 10, 2025 -- Radiation therapy can promote the epidermal growth factor receptor (EGFR) ligand amphiregulin, which increases growth of existing metastases in patients...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.